A council that makes recommendations on medication policies for the Kentucky Horse Racing Commission will go along with several changes in withdrawal times and threshold levels.
The Jockey Club has called on leading industry organizations to come together to conduct a Salix study that would examine the timing of administration on the medication used to prevent exercise-induced pulmonary hemorrhage.
Initial results of a study conducted by the University of Kentucky Gluck Equine Research Center suggest accepted dosage levels for several corticosteroids commonly used in racing should be examined.
If Kentucky is going to join the Mid-Atlantic Uniform Medication Reform's efforts to put uniform medication rules in place in each racing state, it's going to take some work and time.
An initial introduction in Kentucky of the Mid-Atlantic Uniform Medication Program received raised eyebrows, but supporters of the changes are encouraged that the important racing state is giving the program consideration.
The Kentucky Horse Racing Commission May 16 kept alive a proposed regulation to phase out over three years race-day furosemide for graded and listed stakes, but not before the Equine Drug Research Council voted to reject it.
Two panels of the Kentucky Horse Racing Commission have begun the lengthy--and potentially contentious--process of reviewing and revising the state's medication regulations.
Most Popular Stories
- Bal a Bali Vying for U.S. Score in American
- Pletcher Considers Preakness Stakes Options
- Princess Violet Tops Ruffian Stakes Entrants
- KHRC Vote on Salix Threshold Triggers Debate
- Unspurned Seeks Repeat Performance in Hendrie
- Beholder, Warren's Veneda Face Off in Vanity
- Wolf Man Rocket Ships in for Peter Pan Stakes
- NYRA to Cap Belmont Attendance at 90,000
- MarketWatch: Jamie Hill on Sires, Pinhooking
- Hardest Core in Man o' War vs. Imagining